The Paul and Diane Manning Institute of Biotechnology, a planned state-of-the-art facility, will be home to researchers exploring how to improve health from the cellular and genetic level. (Illustration by Elkus Manfredi Architects)

The Steering Committee

  • Melina Kibbe - Dean UVA School of Medicine
  • Frederick H. Epstein - Interim Vice President for Research
  • Harry Sontheimer - Chair, Department of Neurosciences
  • Alice Raucher - University Architect
  • Adam Daniel - Vice Provost for Planning
  • George Southwell - Associate Director for UVA Health Construction

The Steering Committee has been meeting biweekly to plan the new biotechnology building. The four-story, 350,000-square-foot building will be located in Fontaine Research Park (see below) and will include laboratory space, expanded research facilities, core facilities and an area for researchers and partnering biotechnology companies. The facility will also provide amenities for the research park, including a café and conference center to encourage collaboration among researchers within the park and across Grounds.

The design team, led by Elkus Manfredi Architects, worked with the Architect for the University, owner’s representative CBRE, and representatives of the School of Medicine, Office of the Provost, and Facilities Management to develop the design. The final plans will be presented to the board in December 2023.

“The Manning Institute of Biotechnology will be a highly efficient, state-of-the-art facility that will provide modern, flexible, modular, multi-use research laboratory and support space,” said Alice Raucher, architect for the University. “The institute will have the necessary research laboratory infrastructure to accommodate a wide range of disciplines, including neuroscience, bioengineering and medicinal chemistry.”

Site plan for Paul and Diane Manning Institute of Biotechnology